Validation and Clinical Utility of the Lung Sliding Index (LSI) for Differentiating Pulmonary Diseases
Recruiting · NCT06983366 · Observational (researchers observe without assigning treatment) · Lead sponsor: Assiut University
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
This upcoming case-control study aims to confirm the Lung Sliding Index (LSI), a new ultrasound score that measures how well the pleura moves, in various lung diseases. The study will check how well the LSI can tell apart different lung diseases (like pneumothorax, interstitial lung disease, COPD, pneumonia, and pulmonary edema), how it relates to signs of disease severity, and how consistent the results are between different operators who have received the same training. Secondary objectives include assessing patient and operator satisfaction and feasibility using validated Likert scales.
Who can take part
Inclusion criteria
- Age 18 years and older.
- Diagnosed with one of the specified pulmonary diseases, or a healthy control
- Able to provide written informed consent
Exclusion criteria
- Inability to tolerate or undergo a lung ultrasound
- Extensive chest wall pathology precluding assessment
- Unscorable \>2 zones per protocol
- Withdrawal of consent
- Mechanically-ventilated patients
Where it is running
1 location listed.
- Assiut University- Faculty of Medicine - Asyut, Egypt